ALEXIS MARTIN: Open Payments
NPI 1285289488 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$668 in 31 payments from 10 companies in 2025. Trend: 2023 $610 · 2024 $314 · 2025 $668
Food & beverage: $575Education: $93
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 10 | $387 |
| MAYNE PHARMA COMMERCIAL LLC | 9 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| Biogen, Inc. | 2 | $40 |
| SHIELD THERAPEUTICS INC | 2 | $36 |
| MILLICENT US INC | 1 | $24 |
| Organon LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
| Hologic Sales and Service, LLC | 1 | $16 |
| Acella Pharmaceuticals, LLC | 1 | $14 |
Products named: Veozah, Mirena, ZURZUVAE, ACCRUFER, INTRAROSA, NEXPLANON, ZEPBOUND, THINPREP 2000 PROCESSOR.
Industry payments across AR — which companies pay providers there.
